Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study
Frontiers in Microbiology · 25.01.2024 · 15
DOI: 10.3389/fmicb.2024.1336673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 25.01.2024. Verfasst von Xutao Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The link between Gut microbiota (GM) and Gallstone disease (GSD) is well established, but it is not clear whether there is a causal relationship between the two associations.
Methods
We conducted bidirectional Mendelian randomization (MR) analyses, leveraging aggregated data from the Genome-Wide Association Study (GWAS) of GM and Circulating Metabolites. Our primary objective was to investigate the causal interplay between intestinal flora and GSD. Additionally, we performed mediational analyses, two-step MR, and multivariate MR to uncover the potential mediating effect of circulating metabolites in this relationship.
Result
Our study has revealed a causal relationship between GSD and six distinct bacterial groups. Genetically predicted Class Bacilli (Odds Ratio (OR): 0.901, 95% Confidence Interval (95% CI): 0.825–0.985; p = 0.021), Order Lactobacillales (OR: 0.895, 95% CI: 0.816–0.981; p = 0.017), and Genus Coprococcus 2 (OR: 0.884, 95% CI: 0.804–0.973; p = 0.011) were inversely associated with the risk of GSD. Conversely, the Genus Clostridiumsensustricto1 (OR: 1.158, 95% CI: 1.029–1.303; p = 0.015), Genus Coprococcus3 (OR: 1.166, 95% CI: 1.024–1.327; p = 0.020), and Genus Peptococcus (OR: 1.070, 95% CI: 1.017–1.125; p = 0.009) were positively associated with the risk of GSD. Moreover, our findings suggest that the positive influence of the Genus Peptococcus on GSD may be mediated through Omega-3 polyunsaturated fatty acids (PUFA).
Conclusion
This study reinforces the connection between the gut microbiome and the risk of GSD while also unveiling the mediating role of Omega-3 PUFA in the causal relationship between these factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Gastric and Colorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
Zitieren
APA
Hu, X., Binxu, Q., Shao, G. Z., Huang, Y., & Qiu, W. (2024). Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1336673
Vancouver
Hu X, Binxu Q, Shao GZ, Huang Y, Qiu W. Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1336673
BibTeX
@article{Hu2024,
author = {Hu, Xutao and Binxu, Qiu and Shao, Guang-Zhao and Huang, Yu and Qiu, Wei},
title = {Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1336673}
}
EUVIMED